Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
Clinical trial NCT05004025 · COMPLETED
Trial details
- NCT number
- NCT05004025
- Sponsor
- HonorHealth Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2024-11-18
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.